Quantcast

Latest Stem cell treatments Stories

2014-04-02 11:30:25

Animal study points to promise of gene therapy for treating spinal cord injury Delivering a single injection of a scar-busting gene therapy to the spinal cord of rats following injury promotes the survival of nerve cells and improves hind limb function within weeks, according to a study published April 2 in The Journal of Neuroscience. The findings suggest that, with more confirming research in animals and humans, gene therapy may hold the potential to one day treat people with spinal cord...

2014-04-01 15:21:02

Researchers report they can generate human motor neurons from stem cells much more quickly and efficiently than previous methods allowed. The finding, described in Nature Communications, will aid efforts to model human motor neuron development, and to understand and treat spinal cord injuries and motor neuron diseases such as amyotrophic lateral sclerosis (ALS). The new method involves adding critical signaling molecules to precursor cells a few days earlier than previous methods...

2014-04-01 08:30:20

Safety, Efficacy, Patient Satisfaction Drive StemGenex' Efforts toward Best-in-Class Stem Cell Treatment LA JOLLA, Calif., April 1, 2014 /PRNewswire/ -- StemGenex®, the leading resource for adult adipose stem cell therapy in the US aimed at improving the lives of patients dealing with degenerative diseases today reinforced their commitment to attaining the highest treatment standards in the U.S. StemGenex believes by focusing on three key areas of treatment, patients will continue...

2014-03-31 08:30:29

Company Generates Record Cash Flow from Operations of $500,000, up 509% LAS VEGAS, March 31, 2014 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced financial results for the year ended December 31, 2013. Full Year Ended December 31, 2013 Highlights -- Recurring revenues increased approximately 14% to $3.05 million for the year ended 2013, which represents 51% of total revenue. --...

2014-03-28 08:27:33

First Study To Validate Cell Survival and Functionality in Brain, Improvement Dose Dependent ROCKVILLE, Md., March 28, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that a study published in the peer-reviewed journal, PLOS ONE, showed that ischemic-stroke rats transplanted with Neuralstem's NSI-566 stem cells in the brain experienced functional improvements. Furthermore, the grafts both survived and differentiated into neurons. These findings further validate the...

2014-03-26 23:30:02

RSCI’s one-day treatment program in Florida, USA, is priced to bring stem cell treatment benefits to the greatest possible number of SCI patients. Dallas, TX (PRWEB) March 26, 2014 The Repair Stem Cells Institute (RSCI – http://www.repairstemcells.org) announces its new “Double Benefits for SCI” stem cell treatment program specifically to benefit sufferers of Spinal Cord Injuries (SCI). The Regenerative Center, headed by Dr. Melvin M. Propis, a well-known practitioner of stem...

2014-03-26 23:03:19

First use will be in NIH clinical research study and protocol to study the use of bone marrow stem cells during cardiac surgery to treat heart muscle dysfunction associated with ischemic heart disease or damage from heart attack. Fayetteville, Arkansas (PRWEB) March 26, 2014 CardioWise, Inc. and the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) have signed a Beta Site Agreement to serve as a clinical test site for CardioWise Multiparametric Strain...

2014-03-21 23:25:50

A public seminar offered by the Irvine Stem Cell Treatment Center about the use of stem cells for various degenerative and inflammatory conditions. Irvine, CA (PRWEB) March 21, 2014 The Irvine Stem Cell Treatment Center, PC, located in Irvine, CA, announces a free public seminar on the use of stem cells for various degenerative and inflammatory conditions. They will be provided by Dr. Thomas A. Gionis, Surgeon-in-Chief. The seminar will be held on March 23, 2014 at 2:00pm PSTat 3500...

2014-03-21 23:24:15

Stem Cell Training Inc., a subsidiary of Global Stem Cells Group, Inc., and Bioheart, Inc. have announced the completion of their first U.S.-based adipose tissue and bone marrow stem cell extraction training course. Miami (PRWEB) March 21, 2014 Stem Cell Training, Inc., a division of the Global Stem Cells Group, and Bioheart, Inc. have announced the successful completion of their first joint stem cell training course held in the U.S. Titled “Adipose Derived Harvesting, Isolation and...

2014-03-20 23:03:54

The treatment study using autologous (the patient’s own) adult stem cells will be conducted in the USA in April and will be available to the general public. Dallas, TX (PRWEB) March 20, 2014 The Repair Stem Cells Institute (RSCI) -- http://www.repairstemcells.org -- is pleased to announce that it will assist interested patients to take part in a patient-sponsored research study based in the United States for the treatment of Type2 Diabetes with adult stem cells. The study, which meets...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related